This Anthrax Vaccine is a product of the growth of Sterne
strain of anthrax bacillus rendered sterile by filtration and containing 0.005% w/v thiomersal as preservative.
When Anthrax Vaccine (Alum Precipitated Anthrax Antigens)
is used for the active immunisation of man against the various forms of anthrax four doses of 0.5ml should be given intramuscularly. The first three doses should be given at intervals of three weeks, followed by a fourth dose at
an interval of six months. Reinforcing doses of 0.5ml
intramuscularly should be given annually.
This ampoule must be WELL SHAKEN before drawing up the dose
in a sterile syringe. Inoculations should be given intramuscularly, preferably in the deltoid muscle, as there is greater risk of local reactions when this vaccine is given subcutaneously.
Reactions are uncommon but, occasionally, mild erythema or
swelling lasting for about two days may occur at the site of inoculation or even at the site of a previous injection of the vaccine. More rarely regional lymphadenopathy, mild febrile reactions, urticaria or other allergic manifestations may occur. The occurrence of a reaction after a first injection does not necessarily indicate a predisposition to subsequent reactions on further injections.
When using this vaccine the batch number should be recorded, in the recipients records.
The vaccine should be kept at temperatures between 20C and
80C, freezing must be avoided.
Top of Page | Current Section Index |
---|